Improved Synthesis and Crystal Structure of Dalcetrapib
AbstractAn improved synthesis of the Cholesteryl Ester Transfer Protein inhibitor dalcetrapib is reported. The precursor disulfide was reduced (a) by Mg/MeOH or (b) by EtSH/DBU/THF. The resulting thiol was acylated (a) by a known procedure or (b) in a one-pot process. Impurities were removed (a) by dithiothreitol (DTT) or (b) by oxidation using H2O2. Dalcetrapib crystallized in space group P21/c. View Full-Text
- Supplementary File 1:
CIF-Document (CIF, 23 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Laus, G.; Kahlenberg, V.; Richter, F.; Nerdinger, S.; Schottenberger, H. Improved Synthesis and Crystal Structure of Dalcetrapib. Crystals 2012, 2, 1455-1459.
Laus G, Kahlenberg V, Richter F, Nerdinger S, Schottenberger H. Improved Synthesis and Crystal Structure of Dalcetrapib. Crystals. 2012; 2(4):1455-1459.Chicago/Turabian Style
Laus, Gerhard; Kahlenberg, Volker; Richter, Frank; Nerdinger, Sven; Schottenberger, Herwig. 2012. "Improved Synthesis and Crystal Structure of Dalcetrapib." Crystals 2, no. 4: 1455-1459.